DSG Partners with Biotech Company to Battle Progressive and Chronic Kidney Disease
Monday February 01, 2010 - 06:00 AM EST
Released By DSG Inc.
DSG’s electronic data capture and data management vital to two ongoing clinical trials

DSG’s eCaseLink™ Electronic Data Capture (EDC) and data management are currently being used by a biotechnology company for two current phase 2 and phase 2a clinical trials for treatments of progressive and chronic kidney disease. The company uses DSG’s eCaseLink™ to automate and manage the data collection process during the clinical trial lifecycle. In addition, DSG combines data management services with eCaseLink™ to seamlessly optimize data collection and analysis.

The result is clean clinical trial data, collected and analyzed efficiently. This accelerates the clinical trial process, helping to safely speed these treatments to those who need them.

The phase 2 study, is a new treatment that may help people in the early stage of diabetic nephropathy, a progressive kidney disease. The second study, currently in phase 2a, is a treatment for anemia in chronic kidney disease.

The two clinical trials demand a data capture and management solution that speeds time-to-market while complying with all appropriate regulatory procedures. eCaseLink™ EDC provides real-time, clean data, which facilitates quick data review, reporting and decision making for the company.

The eCaseLink™ system is a critical tool for the investigator site and monitoring personnel, in part because it greatly reduces the amount of time it takes to “lock” the clinical database. Database lock occurs once all data has been verified and cleaned through the data management process. Once “locked,” the study’s statistical analysis is performed and results are reported.

“Partnering with innovative drug companies like this, helping to find ways to help those suffering from progressive and chronic kidney disease, is an ideal way for DSG’s unique eCaseLink™ EDC system to be employed in clinical trials,” said Tony Varano, CEO of DSG.

About DSG

DSG Inc. supports clinical trial data collection and management with innovative technology solutions including Electronic Data Capture with specialized Clinical Data Management services, Electronic Patient Diaries, Clinical Trial Management Systems and digital on-demand Case Report Form publishing management software. DSG’s products allow user-friendly, accurate and efficient data capture at any investigator site regardless of the technological infrastructure. DSG has successfully supported over 1,000 clinical trials for more than 325 companies at over 18,000 sites in over 68 countries. Founded in 1992, DSG is a global company headquartered in Malvern, Pa., with additional offices in the U.S., Japan and India. For more information, please visit www.dsg-us.com.

All products and services mentioned in this announcement are the property of their respective owners.

Contacts:

DSG Inc.
David Grace
+1-484-913-0210 x109
dgrace@dsg-us.com
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Bots go here